BrightSpring Health Services, Inc. Common Stock (BTSG) vs Madrigal Pharmaceuticals, Inc. (MDGL)

A side-by-side comparison of BrightSpring Health Services, Inc. Common Stock and Madrigal Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BTSG vs MDGL

growth of $100 · dividends reinvested · last 3y
BTSG +463.6% (+78.0%/yr)MDGL +121.4% (+30.3%/yr)BTSG compounded faster over this window
200400600Start $10020252026$564$221
BTSG MDGL

BTSG vs MDGL: by the numbers

  • •BTSG is the larger company ($12.42B vs $11.48B market cap).
  • •BTSG is profitable (2.05% net margin) while MDGL runs a net loss (-25.32%).

Metrics side by side

Valuation

MetricBTSGMDGL
P/E ratio47.23N/A
Forward P/E34.81N/A
PEG ratio0.97N/A
P/S ratio0.868.94
P/B ratio6.0621.93
EV / EBITDA22.31N/A
FCF yield3.24%N/A

Profitability

MetricBTSGMDGL
Gross margin12.38%91.48%
Operating margin3.33%-25.13%
Net margin2.05%-25.32%
ROE14.35%-62.07%
ROIC8.97%-37.02%

Growth (annualized)

MetricBTSGMDGL
Revenue CAGR (5Y)18.92%N/A
EPS CAGR (5Y)50.94%N/A
FCF CAGR (5Y)9.24%N/A
Total return CAGR (5Y)N/A44.41%

Frequently asked

Is BTSG or MDGL more profitable?
BTSG runs the higher net margin — BTSG at 2.05% versus MDGL at -25.32%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.